Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studiesSharon Walmsley, Mounir Ait‐Khaled, Miguel Górgolas et al.|AIDS Research and Therapy|2024Cited by 11